- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about XBI
Recent news which mentions XBI
From MarketWatch
Better late than never: It’s time for an interest-rate shock from the Federal Reserve to fight inflation
June 14, 2022
From MarketWatch
Here’s the ‘defensive twist’ BlackRock recommends for ETF investors in a slowing economy
June 09, 2022
From MarketWatch
From ETF Trends
3 Biotech Stocks to Buy Before They Boom
June 01, 2022
From InvestorPlace
From Benzinga
Biotech stocks get a boost, or plunge, as new clinical data is shared before major cancer meeting
May 27, 2022
From MarketWatch
From Benzinga
From MarketWatch
From MarketWatch
7 Biotech Stocks With Key Catalysts for May
May 11, 2022
From InvestorPlace
Biotech ETFs Could Be in for More Pain Ahead
May 02, 2022
From ETF Trends
4 Undervalued Biotech Stocks to Add to Your Buy List
April 20, 2022
From InvestorPlace
From InvestorPlace
2 Top Biotech Stocks to Buy in April
April 08, 2022
From Motley Fool
From InvestorPlace
ETFs attract strong inflows in March, but not ‘all boats’ were lifted. Here’s where the money flowed—and where it didn’t.
April 07, 2022
From MarketWatch
From InvestorPlace
From Benzinga
Investors Should Take a Look at the Beaten Down Biotech ETFs
March 18, 2022
From ETF Trends
3 Market ETF Stocks to Buy This Week on Fed Jitters
March 14, 2022
From InvestorPlace
2 Biotech Stocks That Could Make You Richer
March 02, 2022
From Motley Fool
3 Moonshot Stocks Insiders Are Buying. What Do They Know?
February 25, 2022
From InvestorPlace
This Trend Is the Biggest Risk to Biotech Investors Right Now
February 21, 2022
From Motley Fool
Get Ready for a Biotech ETF Comeback
February 17, 2022
From ETF Trends
3 Desirable Drug Stocks With Very Promising Pipelines
February 16, 2022
From InvestorPlace
3 Biotech Stocks That Are too Cheap to Ignore
February 10, 2022
From Motley Fool
3 Growth ETFs to Consider Buying During This Correction
January 29, 2022
From Motley Fool
Why Sorrento Therapeutics Stock Is Getting Hammered This Week
January 28, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.